| 000 | 01458 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512140813.0 | ||
| 264 | 0 | _c19720622 | |
| 008 | 197206s 0 0 eng d | ||
| 022 | _a0021-9746 | ||
| 024 | 7 |
_a10.1136/jcp.25.3.252 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRose, D P | |
| 245 | 0 | 0 |
_aOral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone. _h[electronic resource] |
| 260 |
_bJournal of clinical pathology _cMar 1972 |
||
| 300 |
_a252-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aChromatography, Thin Layer |
| 650 | 0 | 4 |
_aContraceptives, Oral _xadverse effects |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlucose Tolerance Test |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKynurenine _xurine |
| 650 | 0 | 4 |
_aMegestrol _xadverse effects |
| 650 | 0 | 4 |
_aMestranol _xadverse effects |
| 650 | 0 | 4 |
_aNorethindrone _xadverse effects |
| 650 | 0 | 4 |
_aPyridoxine _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTryptophan _xmetabolism |
| 650 | 0 | 4 |
_aXanthurenates _xurine |
| 650 | 0 | 4 |
_aortho-Aminobenzoates _xurine |
| 700 | 1 | _aAdams, P W | |
| 773 | 0 |
_tJournal of clinical pathology _gvol. 25 _gno. 3 _gp. 252-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jcp.25.3.252 _zAvailable from publisher's website |
| 999 |
_c5021186 _d5021186 |
||